Draximage Dtpa Injection, Powder, Lyophilized, For Solution
Product Images NDC 65174-288

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Draximage Dtpa (NDC 65174-288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jubilant Draximage Inc., Dba Jubilant Radiopharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 Vials Carton (Dtpa 30 Vial Carton)

DRAXIMAGE DTPA is a kit for the preparation of Technetium Tc 99m Pontetate Injection. Each kit includes a 20 mg vial. No further information is available.*

FDA Label Image

Vial Label (Dtpa Vial Label)

The text describes a MULTI-DOSE, STERILE, NON-PYROGENIC diagnostic solution called DRAXIMAGE DTPA used for intravenous and inhalation purposes. Each Multi-dose Pentetic acid vial contains calcium chloride dihydrate, p-aminobenzoic acid 5mg, stannous chloride dihydrate, and a maximum tin as stannous chloride dihydrate of 385 mg. The drug should be reconstituted and stored at 25°C (77°F) before use. It should be labeled with oxidant-free technetium Tc-99m, stored in a suitable lead shield, and used within 12 hours of labeling. The package insert provides recommended dosage information.*

FDA Label Image

Eq1 (Eq1)

FDA Label Image

Eq2 (Eq2)

FDA Label Image

Figure_1 (Figure 1)

FDA Label Image

Figure2 (Figure 2)

The text seems to be a collection of measurements and labels, it does not provide enough information to generate a useful description.*

FDA Label Image

Radioactive Label (Radioactive Label)

This is a package insert for Technetium Tc 99m Pentetate Injection for radioactive medical imaging purposes. The instructions indicate that the injection should be stored at 25°C (77°F) and used within 12 hours of labeling with oxidant-free technetium Tc-99m while being shielded in a suitable lead shield. Caution is provided regarding the prohibition of dispensing it without a prescription. More information on dosage, administration, and indications is provided in the package insert, and it is manufactured by Jubilant Draximage Inc. located in Quebec, Canada.*

FDA Label Image

Step-6-formula (Step 6 Formula)

This is a formula to calculate the percent bound Tc 99m, which considers the percentages of TcO4- and MTcO2.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.